Compare SRRK & EPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRRK | EPRT |
|---|---|---|
| Founded | 2012 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 6.9B |
| IPO Year | 2018 | 2018 |
| Metric | SRRK | EPRT |
|---|---|---|
| Price | $43.58 | $25.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 20 |
| Target Price | ★ $70.44 | $36.20 |
| AVG Volume (30 Days) | ★ 2.2M | 1.9M |
| Earning Date | 11-13-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 4.99% |
| EPS Growth | N/A | ★ 11.30 |
| EPS | N/A | ★ 0.62 |
| Revenue | N/A | ★ $561,219,000.00 |
| Revenue This Year | N/A | $19.04 |
| Revenue Next Year | $1,978.85 | $15.71 |
| P/E Ratio | ★ N/A | $41.35 |
| Revenue Growth | N/A | ★ 24.82 |
| 52 Week Low | $27.07 | $25.37 |
| 52 Week High | $61.76 | $34.73 |
| Indicator | SRRK | EPRT |
|---|---|---|
| Relative Strength Index (RSI) | 30.08 | 21.67 |
| Support Level | $41.51 | N/A |
| Resistance Level | $50.09 | $31.49 |
| Average True Range (ATR) | 2.34 | 0.52 |
| MACD | -0.63 | -0.04 |
| Stochastic Oscillator | 13.26 | 15.43 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. The Company generally invests in and leases freestanding, single-tenant commercial real estate facilities where a tenant services its customers and conducts activities that are essential to the generation of the tenant's sales and profits.